EX-10.6




			
	Confidential	  	  
 






 EXHIBIT 10.6 

AMENDMENT No. 8 
 TO 

the AGREEMENT 
 dated
21 December 2012 
 between 

LONZA SALES AG 
 and 

NEXVET BIOPHARMA PTY LTD 
 Schedule 2 

Stage 7C *** 
 Schedule 3 

Price and Payment 
  

 

	***	Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. 









			
	Confidential	  	






  
  

 THIS AMENDMENT is made the 10th day of October 2014 

BETWEEN 
  

	1.	LONZA SALES AG, of Muenchensteinerstrasse 38, Ch-4002 Basel, Switzerland (“Lonza”) and 

  

	2.	NEXVET BIOPHARMA PTY LTD, of 9 Meaden Street, South bank, 3006, Victoria, Australia (“Customer”). 


WHEREAS 
  

	A.	Customer and Lonza entered into an agreement dated 21 December 2012 referring to NV-01, (the “Agreement”), under which Lonza is required to perform Services relating to the Cell line and Product
described. 

  

	B.	Customer would like Lonza to carry out additional activities under the Agreement. 

  

	C.	Lonza is prepared to perform the additional activities. 









			
	Confidential	  	






  
  

 NOW THEREFORE it is agreed hereby by the parties to amend the Agreement and perform additional services as
follows: 
  

	1.	Schedule 2 of the Agreement shall be amended to add Stage 7C in their entirety as follows. 


SCHEDULE 2 
 *** 

 
  

	***	Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. 









			
	Confidential	  	






  
  


	2.	Schedule 3 of the Agreement shall be amended by the addition of the following provisions in respect of the additional Stages contained in this Amendment No. 8: 


SCHEDULE 3 
 PRICE AND
TERMS OF PAYMENT 
  

	1.	Price 

 In consideration for Lonza performing the Services as detailed in Schedule 2
Customer shall pay Lonza as follows: 
  

							
	 Stage
	  	 	  	Price (UK £
Sterling) (1)
***	 
	 7C
	  	Material Supply	  			
		  	***	  	£	  	*** 
		  	***	  	£	  	*** 

 Notes: 
  

	 	(1)	As described in Clause 4- “Delivery, Transportation of Product and Customer Tests” of the Agreement, additional costs and expenses incurred by Lonza in arranging insurance and transportation in order to ship
samples, Product, and Cell Line shall be charged to Customer in addition to the price. 


	 	(2)	The price will depend upon the number of assays required. This will only be determined during the optimisation work. This will be discussed and agreed between Lonza and the Customer during the work. 


 

	2.	Payment 

 Payment by Customer of the Price for each Stage shall be made against
Lonza’s invoices as follows: 
  

	2.1	For Stage 7C 

 ***% of material supply price on commencement of the substage 

***% of material supply price on completion of purification 

***% of QC Testing Price on issue of CoT 
  

 

	***	Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. 









			
	Confidential	  	






  
  


	3.	Save as herein provided all other terms and conditions of the Agreement shall remain in full force and effect. 


AS WITNESS WHEREOF the parties have caused this Amendment No. 8 to be executed by their representatives thereunto duly authorised as of the day and year
first written. 
  

					
	NEXVET BIOPHARMA PTY LTD	 	LONZA SALES AG
		
	 Signature:
  

/s/ David Gearing
	 	 Signature:
  

/s/ J. Westedt

		
	Printed Name: David Gearing	 	Printed Name: Westedt
		
	Title: CSO	 	Title: Dir. Mrg. Serv.
		
		 	 Signature:
  

/s/ Nadia Zieger

			
		 	Printed Name:	 	    Nadia Zieger
		 	Title:	 	    Senior Legal Counsel